Menêses Amanda Gomes de, Reis Paula Elaine Diniz Dos, Guerra Eliete Neves Silva, Canto Graziela De Luca, Ferreira Elaine Barros
Departamento de Enfermagem, Universidade de Brasília, Brasília, DF, Brazil.
Departamento de Odontologia, Universidade de Brasília, Brasília, DF, Brazil.
Rev Lat Am Enfermagem. 2018;26:e2929. doi: 10.1590/1518-8345.2035.2929. Epub 2018 May 7.
to evaluate the effects of trolamine in the prevention or treatment of radiation dermatitis.
systematic review and meta-analysis. Detailed individual search strategies for Cinahl, Cochrane Library Central, LILACS, PubMed, and Web of Science were developed in January 2016. A manual search was also performed to find additional references. A grey literature search was executed by using Google Scholar. Two researchers independently read the titles and abstracts from every cross-reference. The risk of bias of the included studies was analyzed by the Cochrane Collaboration Risk of Bias Tool. The quality of evidence and grading of strength of recommendations was assessed using Grades of Recommendation, Assessment, Development and Evaluation (GRADE).
seven controlled clinical trials were identified. The controls used were calendula, placebo, institutional preference / usual care, Aquaphor®, RadiaCare™, and Lipiderm™. The studies were pooled using frequency of events and risk ratio with 95% confidence intervals, in subgroups according to radiation dermatitis graduation.
based on the studies included in this review, trolamine cannot be considered as a standardized product to prevent or treat radiation dermatitis in patients with breast and head and neck cancer.
评估 trolamine 在预防或治疗放射性皮炎中的效果。
系统评价和荟萃分析。2016 年 1 月制定了针对护理学与健康领域数据库(Cinahl)、考克兰图书馆中央对照试验注册库(Cochrane Library Central)、拉丁美洲及加勒比地区卫生科学数据库(LILACS)、美国国立医学图书馆生物医学数据库(PubMed)和科学网(Web of Science)的详细单独检索策略。还进行了手工检索以查找其他参考文献。通过谷歌学术进行灰色文献检索。两名研究人员独立阅读每个交叉参考文献的标题和摘要。使用考克兰协作网偏倚风险工具分析纳入研究的偏倚风险。使用推荐分级、评估、制定与评价系统(GRADE)评估证据质量和推荐强度分级。
确定了七项对照临床试验。所使用的对照为金盏花、安慰剂、机构偏好/常规护理、优色林万用膏(Aquaphor®)、Radiacare™ 和 Lipiderm™。根据放射性皮炎分级,在亚组中使用事件发生率和风险比以及 95%置信区间对研究进行汇总。
基于本综述中纳入的研究,trolamine 不能被视为预防或治疗乳腺癌及头颈癌患者放射性皮炎的标准化产品。